Robert Hoffman

Robert Hoffman

Directeur Général chez CYTODYN INC.

Fortune : 8 134 $ au 30/09/2026

60 ans
Health Technology
Technology Services
Health Services

Profil

Mr. Robert E.
Hoffman
, CPA, is a Chief Executive, Financial & Accounting Officer at CytoDyn, Inc. and an Independent Director at FibroBiologics, Inc. He is on the Board of Directors at TuHURA Biosciences, Inc., FibroBiologics, Inc. and Day For Change.
Mr. Hoffman was previously employed as an Independent Director by Esperion Therapeutics, Inc., an Independent Director by Saniona AB, a Chairman by Antibe Therapeutics, Inc., an Independent Non-Executive Director by Aslan Pharmaceuticals Ltd., an Independent Director by Aravive, Inc., an Independent Director by Versartis, Inc., a Chairman, President, Chief Executive Officer & CFO by Kintara Therapeutics, Inc., a Chief Financial Officer & Senior VP-Finance by Heron Therapeutics, Inc., a Chief Financial & Accounting Officer, Executive VP by Innovus Pharmaceuticals, Inc., a Chief Financial Officer by AnaptysBio, Inc., an Independent Director by Kura Oncology, Inc., an Independent Director by MabVax Therapeutics Holdings, Inc., an Independent Director by CombiMatrix Corp., a Chief Financial Officer by Polaris Group, Inc., a President & Director by Financial Executives International of San Diego Chapter, a Chief Financial Officer & Senior VP-Finance by Arena Pharmaceuticals, Inc., an Assistant Controller by Document Sciences Corp., a Chief Financial Officer & Senior VP-Finance by Arena Pharmaceuticals, Inc., and an Independent Director by ASLAN Pharmaceuticals Pte Ltd. He also served on the board at Zeta Acquisition Corp.
III and Telik, Inc. He received his undergraduate degree from St. Bonaventure University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
0,01%
26/06/2026 3 641 ( 0,01% ) 7 646 $ 30/09/2026
20/07/2026 375 ( 0,01% ) 488 $ 30/09/2026

Postes actifs de Robert Hoffman

SociétésPosteDébut
FIBROBIOLOGICS, INC. Directeur/Membre du Conseil 08/04/2021
CYTODYN INC. Directeur Général 20/10/2026
Directeur/Membre du Conseil -

Anciens postes connus de Robert Hoffman

SociétésPosteFin
ESPERION THERAPEUTICS, INC. Directeur/Membre du Conseil 13/07/2026
KINTARA THERAPEUTICS, INC. Directeur Général 01/10/2024
Directeur/Membre du Conseil 17/07/2024
ANTIBE THERAPEUTICS INC. Président 24/04/2024
SANA AB Directeur/Membre du Conseil 25/05/2022
Voir l'expérience en détail de Robert Hoffman

Formation de Robert Hoffman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

24

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées24

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Miscellaneous

Health Technology

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Robert Hoffman